Vanguard Group’s BIO-key International BKYI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$18.8K Sell
3,485
-208
-6% -$1.59K ﹤0.01% 4309
2025
Q3
$26.6K Buy
+3,693
New +$28.8K ﹤0.01% 4327
2023
Q4
Sell
-608
Closed -$59.1K 4501
2023
Q3
$59.1K Hold
608
﹤0.01% 4390
2023
Q2
$82.3K Hold
608
﹤0.01% 4406
2023
Q1
$76.6K Hold
608
﹤0.01% 4425
2022
Q4
$64K Sell
608
-820
-57% -$178K ﹤0.01% 4426
2022
Q3
$393K Hold
1,428
﹤0.01% 4279
2022
Q2
$455K Hold
1,428
﹤0.01% 4314
2022
Q1
$617K Hold
1,428
﹤0.01% 4346
2021
Q4
$568K Hold
1,428
﹤0.01% 4409
2021
Q3
$905K Hold
1,428
﹤0.01% 4269
2021
Q2
$977K Buy
1,428
+525
+58% +$345K ﹤0.01% 4152
2021
Q1
$567K Buy
903
+489
+118% +$353K ﹤0.01% 4112
2020
Q4
$262K Buy
414
+360
+667% +$228K ﹤0.01% 4060
2020
Q3
$34K Hold
54
﹤0.01% 4083
2020
Q2
$69K Hold
54
﹤0.01% 4013
2020
Q1
$72K Hold
54
﹤0.01% 3977
2019
Q4
$39K Sell
54
-38
-41% -$31K ﹤0.01% 4057
2019
Q3
$82K Sell
92
-2
-2% -$2.74K ﹤0.01% 4049
2019
Q2
$167K Hold
94
﹤0.01% 4003
2019
Q1
$198K Buy
94
+1
+1% +$1.66K ﹤0.01% 3926
2018
Q4
$100K Buy
93
+67
+258% +$119K ﹤0.01% 4000
2018
Q3
$52K Buy
+26
New +$71.9K ﹤0.01% 4124

Other funds holding BKYI

Vanguard Group's BKYI Position: Q4 2025 in Review

Vanguard Group reduced its BIO-key International (BKYI) stake by 5.6% in Q4 2025, selling an estimated $1.59K and leaving 3,485 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4309.

Vanguard Group first reported a position in BKYI in Q3 2018 and has held it in 23 quarters since. The position peaked at $977K in Q2 2021. 14 funds tracked by Wall St. Rank hold BKYI as of Q4 2025.

  • Vanguard Group held 3,485 shares of BIO-key International worth $18.8K as of Q4 2025.
  • Vanguard Group sold 208 BIO-key International shares in Q4 2025, an estimated $1.59K.
  • BIO-key International made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4309 holding.
  • Vanguard Group first reported a position in BIO-key International in Q3 2018 and has held it in 23 quarters since.
  • Vanguard Group's BIO-key International position peaked at $977K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held BIO-key International as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.